We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current OTLK market cap is 113.34M. The company's latest EPS is USD -4.5327 and P/E is -1.93.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -15.67M | -6.86M | -18.15M | -12.47M | -10.32M |
| Net Income | -18.66M | -6.65M | -20.68M | -12.99M | -11.37M |
| Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 8.15M | 0 | 0 | 0 | 0 |
| Operating Income | -36.3M | -36.84M | -51.77M | -63.12M | -53.14M |
| Net Income | -36.04M | -48.87M | -53.16M | -66.05M | -58.98M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 62.69M | 54.02M | 44.45M | 32.3M | 21.69M |
| Total Liabilities | 46.93M | 43.54M | 49.95M | 46.74M | 46.03M |
| Total Equity | 15.76M | 10.49M | -5.5M | -14.44M | -24.34M |
| Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 17.14M | 19.73M | 22.81M | 28.53M | 32.3M |
| Total Liabilities | 27.91M | 16.91M | 18.2M | 19.79M | 46.74M |
| Total Equity | -16.13M | 2.83M | 4.61M | 8.74M | -14.44M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -8.9M | -17.02M | -30.23M | -42.97M | -13.03M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 43.85M | 43.25M | 46.54M | 48.97M | -3k |
| Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -32.29M | -31.79M | -54.25M | -56.67M | -42.97M |
| Investing | -437k | -900k | N/A | N/A | N/A |
| Financing | 39.03M | 37.21M | 56.19M | 59.59M | 48.97M |
| Market Cap | 113.34M |
| Price to Earnings Ratio | -1.93 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 4.87 |
| Price to Book Ratio | -7.89 |
| Dividend Yield | - |
| Shares Outstanding | 13.01M |
| Average Volume (1 week) | 179.88k |
| Average Volume (1 Month) | 250.9k |
| 52 Week Change | -61.46% |
| 52 Week High | 40.60 |
| 52 Week Low | 4.004 |
| Spread (Intraday) | 0.07 (0.8%) |
| Company Name | Outlook Therapeutics Inc |
| Address |
800 north state street dover, delaware 19901 |
| Website | https://www.outlooktherapeutics.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
